Investigators harness machine learning to evaluate response to sertraline treatment for major depressive disorder.
Study Shows Potential of Artificial Intelligence in Predicting Responses to Treatment for Major Depressive Disorder
You May Also Like
Global Launch Strategies in the Current Political Climate
February 19, 2025
FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk
February 19, 2025
Navigating Distrust: Pharma in the Age of Social Media
February 18, 2025
+ There are no comments
Add yours